A
Adel Gad
Researcher at Karolinska Institutet
Publications - 20
Citations - 3613
Adel Gad is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Breast cancer & Mass screening. The author has an hindex of 14, co-authored 20 publications receiving 3551 citations. Previous affiliations of Adel Gad include National Board of Health and Welfare & International Agency for Research on Cancer.
Papers
More filters
Journal ArticleDOI
REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY: Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare
Laszlo Tabar,Laszlo Tabar,Laszlo Tabar,Adel Gad,Adel Gad,Adel Gad,L. H. Holmberg,L. H. Holmberg,L. H. Holmberg,U. Ljungquist,U. Ljungquist,U. Ljungquist,C.J.G Fagerberg,C.J.G Fagerberg,C.J.G Fagerberg,L. Baldetorp,L. Baldetorp,L. Baldetorp,O Gröntoft,O Gröntoft,O Gröntoft,B. Lundström,B. Lundström,B. Lundström,J. C. Månson,J. C. Månson,J. C. Månson,Gunnar Eklund,Gunnar Eklund,Gunnar Eklund,N.E Day,N.E Day,N.E Day,F. Pettersson,F. Pettersson,F. Pettersson +35 more
TL;DR: 7 years after the start of the study the excess of stage I cancers in the study group largely outweighs the deficit of advanced cancers, and the results to the end of 1984 show a 31% reduction in mortality from breast cancer and a 25% reduced in the rate of stage II or more advanced breast cancers.
Journal Article
Update of the Swedish two-county program of mammographic screening for breast cancer
TL;DR: Analysis of survival showed that relative to the control group, the cancers detected at prevalence screen, incidence screens, and in the interval between screens had a good prognosis, whereas cancers detected in those who had refused screening had a very poor prognosis.
Journal ArticleDOI
Efficacy of breast cancer screening by age. New results swedish two-county trial
Laszlo Tabar,Gunnar Fagerberg,Hsiu-Hsi Chen,Stephen W. Duffy,Charles R. Smart,Adel Gad,Robert A. Smith +6 more
TL;DR: A small effect of breast cancer screening on breast cancer mortality in women aged younger than 50 years compared with older women and various possible reasons have been suggested are suggested.
Journal ArticleDOI
Breast screening, prognostic factors and survival--results from the Swedish two county study.
Stephen W. Duffy,László Tabár,Gunnar Fagerberg,Adel Gad,O Gröntoft,M. C. South,Nicholas E. Day +6 more
TL;DR: Examination of the relationships among the prognostic factors and mode of detection indicates that malignancy grade, as a measure of inherent malignant capacity, evolves as a tumour grows.
Journal ArticleDOI
Tumour development, histology and grade of breast cancers: Prognosis and progression
TL;DR: There was strong evidence of a potential to dedifferentiation, according to which a cancer of mixed malignancy grade drifts towards grade 3 as the more poorly differentiated part of the tumour grows faster than the well‐differentiated part, in women aged 40–49.